Dr. Majed Altareb (he/him) MD

Adult hematologist with subspecialty expertise in malignant hematology, stem cell transplantation, and cellular therapies including CAR T-cell therapy. Completed advanced Cell Therapy and stem cell transplant Fellowship training at Princess Margaret Hospital, University of Toronto. Active in clinical research, academic teaching, and multidisciplinary patient care, with scholarly work presented at international conferences. Committed to delivering evidence-based care and advancing innovation in hematologic malignancies.

Adult hematology with a focus on malignant hematology, lymphoma, stem cell transplantation, and cellular therapies including CAR T-cell therapy. Interest in evidence-based care, quality improvement, and multidisciplinary patient management.

Clinical researcher with interests in lymphoma and cellular therapy outcomes, transplant-related complications, and real-world studies in hematologic malignancies. Presented research at international meetings including ASH, EBMT, EHA, SOHO and actively involved in manuscript development.

Experience teaching residents, fellows, and medical students through bedside instruction, case-based learning, journal clubs, and academic presentations. Committed to mentorship and advancing hematology education.

Specialist training in Internal Medicine and Adult Hematology. Completed Cell Therapy Fellowship at Princess Margaret Hospital / University of Toronto. Faculty and clinical experience in Canada and internationally.

• Desai N, Altareb M, Remberger M, Chen C, Alfaro Moya T, Al-Shaibani E, Novitzky-Basso I, Pasic I, Lam W, Michelis FV, Gerbitz A, Viswabandya A, Kumar R, Kim DDH, Lipton JH, Mattsson J, Law AD. PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation. Blood Adv. 2025 Feb 11;9(3):660-669. doi: 10.1182/bloodadvances.2024014781. PubMed PMID: 39565954; PubMed Central PMCID: PMC11881745.
• Altareb M, Al-Awwami M, Alfraih F, Alhayli S, Ahmed SO, Shaheen M, Chaudhri N, Alsharif F, Alkhabbaz H, Albabtain AA, Alfayez M, Hanbali A, Alshaibani A, Alotaibi AS, Rasheed W, Algharably A, Almohareb F, Alahmari A, Alzahrani H, Aljurf M, El Fakih R. "Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation". Bone Marrow Transplant. 2023 Jun;58(6):680-686. doi: 10.1038/s41409-023-01950-4. Epub 2023 Mar 23. PubMed PMID: 36959370.
• El Fakih R, Lazarus HM, Muffly L, Altareb M, Aljurf M, Hashmi SK. Historical perspective and a glance into the antibody-based conditioning regimens: A new era in the horizon?. Blood Rev. 2022 Mar;52:100892. doi: 10.1016/j.blre.2021.100892. Epub 2021 Oct 16. Review. PubMed PMID: 34674852.